JP2016504311A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016504311A5 JP2016504311A5 JP2015546770A JP2015546770A JP2016504311A5 JP 2016504311 A5 JP2016504311 A5 JP 2016504311A5 JP 2015546770 A JP2015546770 A JP 2015546770A JP 2015546770 A JP2015546770 A JP 2015546770A JP 2016504311 A5 JP2016504311 A5 JP 2016504311A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- cells
- stro
- progeny
- endothelial dysfunction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736361P | 2012-12-12 | 2012-12-12 | |
| US61/736,361 | 2012-12-12 | ||
| PCT/AU2013/001452 WO2014089623A1 (en) | 2012-12-12 | 2013-12-12 | Treatment of diseases of endothelial dysfunction and inflammation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019123243A Division JP6829288B2 (ja) | 2012-12-12 | 2019-07-01 | 内皮機能不全及び炎症の疾患の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016504311A JP2016504311A (ja) | 2016-02-12 |
| JP2016504311A5 true JP2016504311A5 (enExample) | 2017-01-19 |
| JP6572130B2 JP6572130B2 (ja) | 2019-09-04 |
Family
ID=50933585
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015546770A Active JP6572130B2 (ja) | 2012-12-12 | 2013-12-12 | 内皮機能不全及び炎症の疾患の治療 |
| JP2019123243A Active JP6829288B2 (ja) | 2012-12-12 | 2019-07-01 | 内皮機能不全及び炎症の疾患の治療 |
| JP2021008250A Active JP7201715B2 (ja) | 2012-12-12 | 2021-01-21 | 内皮機能不全及び炎症の疾患の治療 |
| JP2022206042A Pending JP2023030116A (ja) | 2012-12-12 | 2022-12-22 | 内皮機能不全及び炎症の疾患の治療 |
| JP2024111736A Pending JP2024147655A (ja) | 2012-12-12 | 2024-07-11 | 内皮機能不全及び炎症の疾患の治療 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019123243A Active JP6829288B2 (ja) | 2012-12-12 | 2019-07-01 | 内皮機能不全及び炎症の疾患の治療 |
| JP2021008250A Active JP7201715B2 (ja) | 2012-12-12 | 2021-01-21 | 内皮機能不全及び炎症の疾患の治療 |
| JP2022206042A Pending JP2023030116A (ja) | 2012-12-12 | 2022-12-22 | 内皮機能不全及び炎症の疾患の治療 |
| JP2024111736A Pending JP2024147655A (ja) | 2012-12-12 | 2024-07-11 | 内皮機能不全及び炎症の疾患の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160175360A1 (enExample) |
| EP (2) | EP3556850A1 (enExample) |
| JP (5) | JP6572130B2 (enExample) |
| KR (3) | KR102506612B1 (enExample) |
| CN (2) | CN105358163B (enExample) |
| AU (4) | AU2013360024B2 (enExample) |
| CA (1) | CA2893942C (enExample) |
| ES (1) | ES2742035T3 (enExample) |
| IL (1) | IL239308A0 (enExample) |
| SG (2) | SG11201504340YA (enExample) |
| WO (1) | WO2014089623A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101718375B1 (ko) | 2007-12-04 | 2017-03-22 | 프로테오바이오엑티브스 피티와이 엘티디 | 전구 세포의 보호 및 그의 분화 조절 |
| CN105358163B (zh) * | 2012-12-12 | 2020-09-11 | 麦瑟布莱斯特公司 | 内皮功能障碍和炎症的疾病的治疗 |
| WO2022114111A1 (ja) * | 2020-11-27 | 2022-06-02 | マルホ株式会社 | 医薬品又は化粧品用組成物 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| AU8200191A (en) | 1990-07-09 | 1992-02-04 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| ES2239801T3 (es) * | 1997-04-02 | 2005-10-01 | The Brigham And Women's Hospital, Inc. | Uso de un agente para disminuir el riesgo de enfermedad cardiovascular. |
| AUPQ147799A0 (en) | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
| AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| DE19939781C2 (de) | 1999-08-21 | 2003-06-18 | Schott Glas | Skulltiegel für das Erschmelzen oder das Läutern von anorganischen Substanzen, insbesondere von Gläsern und Glaskeramiken |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| CN101506355B (zh) | 2004-09-24 | 2012-06-27 | 成血管细胞系统公司 | 多能扩增间充质前体细胞子代（memp）及其应用 |
| CN101248171B (zh) | 2005-04-12 | 2015-11-25 | 迈索布拉斯特股份有限公司 | 通过组织非特异性碱性磷酸酶分离成人多潜能细胞 |
| CA2608048A1 (en) * | 2005-05-10 | 2006-11-16 | United States Of America Department Of Veteran's Affairs | Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media |
| US20080260703A1 (en) * | 2007-04-23 | 2008-10-23 | Medistem Labortories | Treatment of Insulin Resistance and Diabetes |
| AU2008334036B2 (en) * | 2007-11-30 | 2014-05-29 | New York Medical College | Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells |
| EP2227238A2 (en) * | 2007-11-30 | 2010-09-15 | New York Medical College | Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| KR101718375B1 (ko) * | 2007-12-04 | 2017-03-22 | 프로테오바이오엑티브스 피티와이 엘티디 | 전구 세포의 보호 및 그의 분화 조절 |
| WO2010005527A1 (en) * | 2008-06-30 | 2010-01-14 | Angioblast Systems, Inc. | Treatment of eye diseases and excessive neovascularization using a combined therapy |
| ES2550795T3 (es) * | 2008-11-20 | 2015-11-12 | Mesoblast, Inc. | Método para tratar o prevenir una disfunción pancreática |
| WO2010138180A2 (en) * | 2009-05-26 | 2010-12-02 | The University Of Vermont And State Agriculture College | Compositions and methods for cardiac tissue repair |
| WO2011073521A1 (en) * | 2009-12-15 | 2011-06-23 | Petri Salven | Methods for enriching adult-derived endothelial progenitor cells and uses thereof |
| WO2012047733A2 (en) * | 2010-09-29 | 2012-04-12 | Aidan Research And Consulting, Llc. | Treatment of acne by conditioned media |
| US9405700B2 (en) | 2010-11-04 | 2016-08-02 | Sonics, Inc. | Methods and apparatus for virtualization in an integrated circuit |
| AU2012262675B2 (en) * | 2011-06-03 | 2016-05-19 | Mesoblast, Inc | Methods of treating or preventing neurological diseases |
| CA2839341C (en) * | 2011-07-04 | 2020-12-15 | Mesoblast, Inc. | Methods of treating or preventing rheumatic disease |
| EP2879682B1 (en) * | 2012-08-01 | 2018-03-21 | United Therapeutics Corporation | Treatment of pulmonary arterial hypertension with mesenchymal stem cells |
| CN105358163B (zh) * | 2012-12-12 | 2020-09-11 | 麦瑟布莱斯特公司 | 内皮功能障碍和炎症的疾病的治疗 |
| EP2943069B1 (en) * | 2013-01-09 | 2018-08-15 | United Therapeutics Corporation | Treatment of vasculopathy with prostacyclin and mesenchymal stem cells |
-
2013
- 2013-12-12 CN CN201380072732.5A patent/CN105358163B/zh active Active
- 2013-12-12 US US14/650,172 patent/US20160175360A1/en not_active Abandoned
- 2013-12-12 SG SG11201504340YA patent/SG11201504340YA/en unknown
- 2013-12-12 KR KR1020227005920A patent/KR102506612B1/ko active Active
- 2013-12-12 AU AU2013360024A patent/AU2013360024B2/en active Active
- 2013-12-12 KR KR1020157017531A patent/KR102217962B1/ko active Active
- 2013-12-12 KR KR1020217004422A patent/KR102367981B1/ko active Active
- 2013-12-12 JP JP2015546770A patent/JP6572130B2/ja active Active
- 2013-12-12 WO PCT/AU2013/001452 patent/WO2014089623A1/en not_active Ceased
- 2013-12-12 ES ES13862555T patent/ES2742035T3/es active Active
- 2013-12-12 SG SG10201705061RA patent/SG10201705061RA/en unknown
- 2013-12-12 EP EP19174698.1A patent/EP3556850A1/en active Pending
- 2013-12-12 CN CN202010796960.9A patent/CN111840329B/zh active Active
- 2013-12-12 EP EP13862555.3A patent/EP2931876B1/en active Active
- 2013-12-12 CA CA2893942A patent/CA2893942C/en active Active
-
2015
- 2015-06-09 IL IL239308A patent/IL239308A0/en unknown
-
2019
- 2019-04-29 AU AU2019202960A patent/AU2019202960B2/en active Active
- 2019-07-01 JP JP2019123243A patent/JP6829288B2/ja active Active
-
2021
- 2021-01-21 JP JP2021008250A patent/JP7201715B2/ja active Active
- 2021-10-12 AU AU2021250848A patent/AU2021250848A1/en not_active Abandoned
-
2022
- 2022-12-22 JP JP2022206042A patent/JP2023030116A/ja active Pending
-
2023
- 2023-10-04 US US18/481,041 patent/US20240115618A1/en active Pending
-
2024
- 2024-07-11 JP JP2024111736A patent/JP2024147655A/ja active Pending
- 2024-10-10 AU AU2024227208A patent/AU2024227208A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Van Dijk et al. | The complex mural cell: pericyte function in health and disease | |
| Tousoulis et al. | Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches | |
| JP2013523152A5 (enExample) | ||
| CL2013003331A1 (es) | Tableta de liberacion inmediata a prueba de alteracion que comprende (i) una matriz, y (ii) una pluralidad de material particulado, que comprende un opiaceo y un polimero de oxido de polietileno de mas de 20.000 g/mol, donde el multiparticulado forma una fase discontinua dentro de la matriz. | |
| JP2012530141A5 (enExample) | ||
| JP2018505158A5 (enExample) | ||
| PH12018500261A1 (en) | Azole benzene derivative | |
| JP2017526619A5 (enExample) | ||
| JP2016511753A5 (enExample) | ||
| JP2016504311A5 (enExample) | ||
| JP2016502980A5 (enExample) | ||
| Jain et al. | Antihypertensive drugs aliskiren, nebivolol, and olmesartan reduce hypertension by reducing endothelial microparticles and regulating angiogenesis | |
| JP2012515165A5 (enExample) | ||
| WO2010091051A3 (en) | Therapeutic use of specialized endothelial progenitor cells | |
| JP2016503794A5 (ja) | 疾患の治療のための医薬組成物 | |
| JP2014533256A5 (enExample) | ||
| CN103550755B (zh) | 一种氟苯尼考硫酸粘菌素可溶性粉及其制备方法 | |
| JP2018510917A5 (enExample) | ||
| WO2021057061A1 (en) | Senolytic and antiinflammatory prodrugs and methods of use thereof | |
| CN104398525B (zh) | 闭花木酮的o-(哌嗪基)乙基衍生物在制备抗慢性阻塞性肺病药物中的应用 | |
| CN106008560B (zh) | 一种双小檗碱衍生物的制备方法和用途 | |
| CN104622883B (zh) | 用于治疗动脉粥样硬化的药物制剂及其制备方法 | |
| CN104644648A (zh) | 闭花木酮的o-(三唑基)乙基衍生物在制备抗慢性阻塞性肺病药物中的应用 | |
| CN102861054B (zh) | Houttuynoid D在制备抑制肝脏成纤维细胞增殖药物中的应用 | |
| Berezin et al. | Cellular Care and Extracellular Vesicles Therapies of Heart Failure |